Diagnostics News and Research

RSS

New approaches needed for testing cancer drugs

Research institutes, regulators and the pharmaceutical industry are urged to cooperate to develop new approaches to testing cancer drugs, in order to bring the revolution in personalised medicine to patients across Europe, says the European Society for Medical Oncology.

1 Oct 2013

Pfizer Licenses Gliknik's Pooled IVIG In $25M+ Deal

...

30 Sep 2013

GSK Sells Thrombosis Brands To Aspen For $1.13B

...

30 Sep 2013

Merck Canada Gives Patient-Oriented Research $4M Boost

...

30 Sep 2013

Minimally invasive treatments for lumbar spinal stenosis: an interview with James Corbett, President & Chief Executive Officer of Vertos Medical

Lumbar spinal stenosis (LSS) is a degenerative, age-related narrowing of the lower spinal canal that causes pressure on the nerves, leading to pain and reduced mobility. Symptoms include pain, numbness, or tingling in the lower back, legs, or buttocks, which limits your ability to stand or walk.

30 Sep 2013

Scientists identify 140 regions of genetic code believed to contain undiscovered cancer genes

Scanning the DNA of nearly 5,000 tumor samples, a team led by scientists at Dana-Farber Cancer Institute and the Broad Institute has identified 140 regions of scrambled genetic code believed to contain many undiscovered cancer genes.

29 Sep 2013

Pan-Cancer Initiative: Patterns Emerge Across Diverse Tumor Types

...

27 Sep 2013

SBIR Awards Etubics $1.5M To Manufacture Breast Cancer Immunotherapy

...

27 Sep 2013

Ablynx Nets Another $33.7M From Merck Serono As Partnership Expands

...

27 Sep 2013

Regado Axes 15% Of Staff, Focuses On Phase III Trial

...

27 Sep 2013

University of Maryland receives renewed NIH funding for vaccine research

The University of Maryland School of Medicine's Center for Vaccine Development (CVD) has successfully competed for and received a renewed contract to conduct basic research and clinical studies of vaccines, diagnostics, and therapeutics. Support for this work to combat existing and emerging infectious diseases is provided by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

27 Sep 2013

VVRP receives contract from NIH to continue its work as Vaccine and Treatment Evaluation Units

The Vanderbilt Vaccine Research Program (VVRP) has received a contract from the National Institutes of Health (NIH) to continue its work as one of the nation's Vaccine and Treatment Evaluation Units (VTEU).

27 Sep 2013

New hepatitis virus reported by scientists was a false alarm

The report by scientists of a new hepatitis virus earlier this year was a false alarm, according to UC San Francisco researchers who correctly identified the virus as a contaminant present in a type of glassware used in many research labs.

27 Sep 2013

Allergan Licenses Rights To Medytox Candidates, In Up-To-$362M Deal

...

26 Sep 2013

Biosearch Technologies Acquires Majority Stake In Lightspeed Genomics

...

26 Sep 2013

Pittcon to exhibit at BioConference Live’s “Cancer: Research, Discovery and Therapeutics” online-only event

Pittcon is pleased to announce it will be exhibiting at the next BioConference Live virtual event. BioConference Live, the largest producer of online-only conferences focused on life sciences, laboratory animal sciences and clinical diagnostics, has announced the upcoming “Cancer: Research, Discovery and Therapeutics” online-only conference.

26 Sep 2013

Federal Data Shows R&D Spending Slide

...

25 Sep 2013

Amgen Plans R&D Center In China

...

25 Sep 2013

Global Genomics Group Enlists Illumina For Cardiovascular Disease Study

...

From Illumina, Inc. 25 Sep 2013

NCI Re-Ups Biomarker Strategies’ SBIR Award For Melanoma Cdx

BioMarker Strategies received a $1.5 million SBIR award to develop a pathway-based companion diagnostic test to facilitate the selection of optimal therapy for patients with melanoma. This award was preceded by an NCI award of $200,000 almost two years ago in September 2011.

25 Sep 2013